In this issue:
Implementing low-dose CT lung cancer screening in clinical practice
BTS guidelines for pulmonary nodules
Negative predictive value of TTNB
Community pulmonologists’ management of pulmonary nodules
EBUS-TBNA for lung cancer diagnosis and staging
England’s urgent referral pathway for suspected cancer reduces mortality
AZD9291 active in EGFR inhibitorresistant NSCLC
Rociletinib active in EGFR-mutated NSCLC
cfDNA level is a prognostic biomarker in lung cancer
Nivolumab better than docetaxel in advanced squamous-cell NSCLC
1% lidocaine spray as effective as 2% during flexible bronchoscopy
Pleural effusions decrease lung cancer survival
Please login below to download this issue (PDF)